Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer
Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer
Recruiting · NCT03878849 · Registry updated 2025-08-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer | Advanced Ovarian Cancer | Recruiting | Phase 2 | 2025-08-28 | NCT03878849 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alcedis GmbH | 7 |
| Allarity Therapeutics | 2 |
| Amarex Clinical Research | 6 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| OU Health Stephenson Cancer | Oklahoma City | United States | 1 |
| Swedish Center for Research and Innovation | Seattle | United States | 2 |